Sort
261,768 grants matching “gene therapy”
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2022 · HD
TNF Signaling, Cell Death and Cancer
$1,541,254Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Development of new antibody-based cancer therapies
$1,541,067Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
IND-enabling studies of non-immunogenic gene therapy for ultra-rare DMD patients excluded from dystrophin trials
$1,541,019Hansell H Stedman · University Of Pennsylvania · U01 · FY2024 · NS
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr
$1,540,856Eric P Hoffman · Children'S Research Institute · U54 · FY2007 · HD
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
$1,540,837Qijing Li · Duke University · R33 · FY2017 · CA
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)
$1,540,834Jeffrey S Chamberlain · University Of Washington · P50 · FY2020 · AR
Inflammation, Airways Reactivity and Asthma
$1,540,770National Jewish Health · P01 · FY2004 · HL
Functional Analysis of Novel Genes in Eye Development and Vision
$1,540,291Graeme J Wistow · National Eye Institute · ZIA · FY2022 · EY
A comprehensive platform for novel therapy development from the microbiome
$1,540,112Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2020 · DK
INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MAKERS
$1,540,102Johns Hopkins University · U01 · FY2003 · CA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,540,004Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2014 · CA
Development and Preclinical Application of Pancreatic Adenocarcinoma Models
$1,539,864Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Genome Characterization Unit
$1,539,856Jeffrey M. Trent · University Of New Mexico Health Scis Ctr · U2C · FY2020 · CA
Gene and Pharmacological Therapies for Cystic Fibrosis
$1,539,737Johns Hopkins University · P01 · FY2005 · HL
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
$1,539,666Yuri Sergeev · National Eye Institute · ZIA · FY2023 · EY
Studies Of Central Nervous System Functional Anatomy
$1,539,359Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2012 · MH
Model Systems for Development of Pain Gene Therapy
$1,539,351Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · DK
ROLES AND REGULATION OF P53
$1,539,307Columbia Univ New York Morningside · P01 · FY2001 · CA
Stanford University Center for Reproductive and Stem Cell biology
$1,539,283Margaret T Fuller · Stanford University · U54 · FY2013 · HD
Preclinical drug development in pancreatic cancer
$1,539,190Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Clonal analysis of in vivo hematopoiesis
$1,539,113Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
$1,538,751Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,538,751Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,538,676Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · AI